US · Healthcare

Apollomics Inc. Warrant (APLMW)

Biotechnology

Apollomics Inc. Warrant (APLMW) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for APLMW

P/E ratio

18.00

Apollomics Inc. Warrant (APLMW) — FAQ

What is APLMW's P/E ratio?

The price-to-earnings (P/E) ratio for Apollomics Inc. Warrant (APLMW) is 18.00 (data as of 2026-03-23).

Does Apollomics Inc. Warrant pay a dividend?

Dividend yield is not available in the current snapshot for Apollomics Inc. Warrant (APLMW). Check the MyAverix Finance app for the latest dividend data.

What sector is Apollomics Inc. Warrant in?

Apollomics Inc. Warrant (APLMW) is classified in the Healthcare sector (Biotechnology industry).

What exchange is APLMW listed on?

APLMW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)